BBIO
BridgeBio Pharma Inc.
$55.96
+$0.47(+0.85%)
60
Overall
40
Value
90
Tech
50
Quality
Market Cap
$10.37B
Volume
2.23M
52W Range
$21.72 - $55.94
Target Price
$65.65
EPS Estimates Overview
| Current Quarter | $-0.89 | Next Quarter | $-0.79 |
| Current Year | $-3.51 | Next Year | $-2.1 |
| QoQ Growth | +11.2% | YoY Growth | +40.2% |
| 3Y EPS CAGR | +9.6% | Target Price | $65.65 |
| Consensus | Buy | Upside | +17.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $55.96 | +0.8% | 2.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |